nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—hypertension—adrenal gland cancer	0.713	1	CtDrD
Losartan—ABCB1—adrenal gland cancer	0.219	1	CbGaD
Losartan—ACE—renal artery—adrenal gland cancer	0.00877	0.22	CbGeAlD
Losartan—ACE—sympathetic nervous system—adrenal gland cancer	0.00449	0.113	CbGeAlD
Losartan—ACE—vein—adrenal gland cancer	0.0042	0.105	CbGeAlD
Losartan—UGT1A1—urine—adrenal gland cancer	0.00382	0.0958	CbGeAlD
Losartan—ACE—urine—adrenal gland cancer	0.00246	0.0617	CbGeAlD
Losartan—CYP2C19—urine—adrenal gland cancer	0.00207	0.0519	CbGeAlD
Losartan—CYP1A2—urine—adrenal gland cancer	0.00169	0.0424	CbGeAlD
Losartan—SLC2A9—adrenal gland—adrenal gland cancer	0.00166	0.0417	CbGeAlD
Losartan—CYP2C9—urine—adrenal gland cancer	0.0016	0.0403	CbGeAlD
Losartan—CYP3A4—urine—adrenal gland cancer	0.00122	0.0307	CbGeAlD
Losartan—SLCO1B3—pituitary gland—adrenal gland cancer	0.00118	0.0295	CbGeAlD
Losartan—AGTR1—adrenal cortex—adrenal gland cancer	0.000882	0.0221	CbGeAlD
Losartan—AGTR1—cardiac atrium—adrenal gland cancer	0.00073	0.0183	CbGeAlD
Losartan—AGTR1—pituitary gland—adrenal gland cancer	0.000713	0.0179	CbGeAlD
Losartan—AGTR1—adrenal gland—adrenal gland cancer	0.000637	0.016	CbGeAlD
Losartan—ACE—gonad—adrenal gland cancer	0.00054	0.0135	CbGeAlD
Losartan—ACE—cardiac atrium—adrenal gland cancer	0.000539	0.0135	CbGeAlD
Losartan—ACE—pituitary gland—adrenal gland cancer	0.000526	0.0132	CbGeAlD
Losartan—ALB—adrenal gland—adrenal gland cancer	0.000491	0.0123	CbGeAlD
Losartan—ACE—adrenal gland—adrenal gland cancer	0.00047	0.0118	CbGeAlD
Losartan—Telmisartan—ABCB1—adrenal gland cancer	0.000435	0.554	CrCbGaD
Losartan—CYP2C8—pituitary gland—adrenal gland cancer	0.000387	0.0097	CbGeAlD
Losartan—Candesartan—ABCB1—adrenal gland cancer	0.00035	0.446	CrCbGaD
Losartan—ABCB1—adrenal cortex—adrenal gland cancer	0.000229	0.00576	CbGeAlD
Losartan—ABCB1—gonad—adrenal gland cancer	0.00019	0.00477	CbGeAlD
Losartan—ABCB1—pituitary gland—adrenal gland cancer	0.000185	0.00465	CbGeAlD
Losartan—ABCB1—adrenal gland—adrenal gland cancer	0.000166	0.00416	CbGeAlD
Losartan—UGT2B17—Metabolism—ABCB1—adrenal gland cancer	7.63e-05	0.00283	CbGpPWpGaD
Losartan—UGT1A3—Biological oxidations—POMC—adrenal gland cancer	7.53e-05	0.00279	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—IGF2—adrenal gland cancer	7.53e-05	0.00279	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	7.51e-05	0.00279	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	7.39e-05	0.00274	CbGpPWpGaD
Losartan—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.34e-05	0.00273	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	7.17e-05	0.00266	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	6.84e-05	0.00254	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SDHB—adrenal gland cancer	6.73e-05	0.0025	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	6.4e-05	0.00238	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	6.4e-05	0.00238	CbGpPWpGaD
Losartan—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.36e-05	0.00236	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SDHB—adrenal gland cancer	6.34e-05	0.00235	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	6.21e-05	0.0023	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—IGF2—adrenal gland cancer	6.06e-05	0.00225	CbGpPWpGaD
Losartan—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.95e-05	0.00221	CbGpPWpGaD
Losartan—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	5.87e-05	0.00218	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SDHB—adrenal gland cancer	5.72e-05	0.00212	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—GNAS—adrenal gland cancer	5.69e-05	0.00211	CbGpPWpGaD
Losartan—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.68e-05	0.00211	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—GNRH1—adrenal gland cancer	5.64e-05	0.00209	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GNRHR—adrenal gland cancer	5.56e-05	0.00206	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—TSHR—adrenal gland cancer	5.53e-05	0.00205	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	5.31e-05	0.00197	CbGpPWpGaD
Losartan—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	5.24e-05	0.00194	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—POMC—adrenal gland cancer	5.23e-05	0.00194	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—POMC—adrenal gland cancer	5.2e-05	0.00193	CbGpPWpGaD
Losartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.18e-05	0.00192	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.17e-05	0.00192	CbGpPWpGaD
Losartan—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.16e-05	0.00191	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	5.04e-05	0.00187	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TSHR—adrenal gland cancer	5.02e-05	0.00187	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.99e-05	0.00185	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ZNRF3—adrenal gland cancer	4.86e-05	0.0018	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	4.84e-05	0.0018	CbGpPWpGaD
Losartan—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	4.78e-05	0.00177	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.75e-05	0.00176	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SDHB—adrenal gland cancer	4.65e-05	0.00173	CbGpPWpGaD
Losartan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.6e-05	0.00171	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.6e-05	0.00171	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	4.57e-05	0.0017	CbGpPWpGaD
Losartan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	4.42e-05	0.00164	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	4.36e-05	0.00162	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—RRM1—adrenal gland cancer	4.34e-05	0.00161	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SDHD—adrenal gland cancer	4.34e-05	0.00161	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SDHB—adrenal gland cancer	4.26e-05	0.00158	CbGpPWpGaD
Losartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.2e-05	0.00156	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PTGS2—adrenal gland cancer	4.17e-05	0.00155	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—RRM1—adrenal gland cancer	4.09e-05	0.00152	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SDHD—adrenal gland cancer	4.09e-05	0.00152	CbGpPWpGaD
Losartan—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	4.08e-05	0.00152	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—POMC—adrenal gland cancer	4.04e-05	0.0015	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.85e-05	0.00143	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	3.84e-05	0.00143	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—POMC—adrenal gland cancer	3.83e-05	0.00142	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.77e-05	0.0014	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	3.71e-05	0.00138	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SDHD—adrenal gland cancer	3.69e-05	0.00137	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—RRM1—adrenal gland cancer	3.69e-05	0.00137	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PRKACA—adrenal gland cancer	3.61e-05	0.00134	CbGpPWpGaD
Losartan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	3.59e-05	0.00133	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.5e-05	0.0013	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	3.46e-05	0.00129	CbGpPWpGaD
Losartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	3.41e-05	0.00127	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CDC42—adrenal gland cancer	3.37e-05	0.00125	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.35e-05	0.00124	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	3.34e-05	0.00124	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GNRH1—adrenal gland cancer	3.33e-05	0.00124	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—MED12—adrenal gland cancer	3.23e-05	0.0012	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—GNAS—adrenal gland cancer	3.22e-05	0.00119	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.19e-05	0.00118	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	3.16e-05	0.00117	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	3.09e-05	0.00115	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	3.09e-05	0.00115	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CDC42—adrenal gland cancer	3.06e-05	0.00114	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—MED12—adrenal gland cancer	3.05e-05	0.00113	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SPRY2—adrenal gland cancer	3.05e-05	0.00113	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SDHD—adrenal gland cancer	3e-05	0.00111	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—RRM1—adrenal gland cancer	3e-05	0.00111	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TSHR—adrenal gland cancer	2.97e-05	0.0011	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—GNAS—adrenal gland cancer	2.92e-05	0.00108	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CTNNB1—adrenal gland cancer	2.89e-05	0.00107	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.84e-05	0.00105	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SDHB—adrenal gland cancer	2.83e-05	0.00105	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MEN1—adrenal gland cancer	2.79e-05	0.00104	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.79e-05	0.00103	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TP53—adrenal gland cancer	2.78e-05	0.00103	CbGpPWpGaD
Losartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	2.77e-05	0.00103	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—MED12—adrenal gland cancer	2.75e-05	0.00102	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—RRM1—adrenal gland cancer	2.75e-05	0.00102	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SDHD—adrenal gland cancer	2.75e-05	0.00102	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	2.74e-05	0.00102	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.72e-05	0.00101	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.64e-05	0.000981	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.63e-05	0.000975	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.58e-05	0.000959	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.54e-05	0.000941	CbGpPWpGaD
Losartan—ALB—Hemostasis—SPARC—adrenal gland cancer	2.49e-05	0.000926	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SDHB—adrenal gland cancer	2.45e-05	0.000909	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	2.44e-05	0.000907	CbGpPWpGaD
Losartan—ALB—Metabolism—SDHB—adrenal gland cancer	2.43e-05	0.000904	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	2.38e-05	0.000883	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PRKACA—adrenal gland cancer	2.36e-05	0.000876	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.36e-05	0.000875	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—MED12—adrenal gland cancer	2.23e-05	0.000829	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	2.23e-05	0.000827	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PRKACA—adrenal gland cancer	2.22e-05	0.000825	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SDHB—adrenal gland cancer	2.19e-05	0.000811	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.17e-05	0.000806	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—POMC—adrenal gland cancer	2.17e-05	0.000804	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.15e-05	0.000798	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SDHB—adrenal gland cancer	2.13e-05	0.000792	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PRKACA—adrenal gland cancer	2.13e-05	0.000791	CbGpPWpGaD
Losartan—ALB—Hemostasis—PRKACA—adrenal gland cancer	2.1e-05	0.000781	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—MED12—adrenal gland cancer	2.05e-05	0.00076	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	2.01e-05	0.000745	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SDHB—adrenal gland cancer	1.99e-05	0.00074	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—POMC—adrenal gland cancer	1.97e-05	0.00073	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.93e-05	0.000715	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.92e-05	0.000711	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GNAS—adrenal gland cancer	1.91e-05	0.00071	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	1.9e-05	0.000707	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ABCB1—adrenal gland cancer	1.88e-05	0.000696	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.84e-05	0.000682	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.83e-05	0.000679	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.82e-05	0.000676	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—RRM1—adrenal gland cancer	1.82e-05	0.000676	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SDHD—adrenal gland cancer	1.82e-05	0.000676	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDC42—adrenal gland cancer	1.81e-05	0.000671	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GNAS—adrenal gland cancer	1.8e-05	0.000669	CbGpPWpGaD
Losartan—ALB—Hemostasis—CDC42—adrenal gland cancer	1.79e-05	0.000663	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ABCB1—adrenal gland cancer	1.77e-05	0.000656	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.75e-05	0.00065	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IGF2—adrenal gland cancer	1.74e-05	0.000646	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GNAS—adrenal gland cancer	1.73e-05	0.000641	CbGpPWpGaD
Losartan—ALB—Hemostasis—IGF2—adrenal gland cancer	1.72e-05	0.000639	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.72e-05	0.000638	CbGpPWpGaD
Losartan—ALB—Hemostasis—GNAS—adrenal gland cancer	1.71e-05	0.000633	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SDHB—adrenal gland cancer	1.7e-05	0.000632	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IGF1R—adrenal gland cancer	1.68e-05	0.000625	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PRKACA—adrenal gland cancer	1.63e-05	0.000605	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GNAS—adrenal gland cancer	1.63e-05	0.000603	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.6e-05	0.000593	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	1.6e-05	0.000592	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SDHD—adrenal gland cancer	1.58e-05	0.000586	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—RRM1—adrenal gland cancer	1.58e-05	0.000586	CbGpPWpGaD
Losartan—ALB—Metabolism—RRM1—adrenal gland cancer	1.57e-05	0.000582	CbGpPWpGaD
Losartan—ALB—Metabolism—SDHD—adrenal gland cancer	1.57e-05	0.000582	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.57e-05	0.000582	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.57e-05	0.000581	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PRKACA—adrenal gland cancer	1.49e-05	0.000554	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.48e-05	0.000548	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	1.47e-05	0.000546	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.46e-05	0.000542	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TERT—adrenal gland cancer	1.45e-05	0.000538	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.45e-05	0.000538	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SDHD—adrenal gland cancer	1.41e-05	0.000523	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—RRM1—adrenal gland cancer	1.41e-05	0.000523	CbGpPWpGaD
Losartan—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.37e-05	0.00051	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.37e-05	0.00051	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MED12—adrenal gland cancer	1.36e-05	0.000504	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.34e-05	0.000498	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GNAS—adrenal gland cancer	1.32e-05	0.00049	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SDHB—adrenal gland cancer	1.31e-05	0.000488	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ABCB1—adrenal gland cancer	1.3e-05	0.000481	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.29e-05	0.00048	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—POMC—adrenal gland cancer	1.29e-05	0.000478	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SDHD—adrenal gland cancer	1.28e-05	0.000477	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—RRM1—adrenal gland cancer	1.28e-05	0.000477	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—BAD—adrenal gland cancer	1.26e-05	0.000468	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.24e-05	0.00046	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—POMC—adrenal gland cancer	1.21e-05	0.00045	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GNAS—adrenal gland cancer	1.21e-05	0.000449	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ABCB1—adrenal gland cancer	1.19e-05	0.000441	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MED12—adrenal gland cancer	1.18e-05	0.000437	CbGpPWpGaD
Losartan—ALB—Metabolism—MED12—adrenal gland cancer	1.17e-05	0.000434	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—POMC—adrenal gland cancer	1.16e-05	0.000432	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—BRAF—adrenal gland cancer	1.15e-05	0.000426	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EGFR—adrenal gland cancer	1.11e-05	0.000413	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RRM1—adrenal gland cancer	1.1e-05	0.000407	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SDHD—adrenal gland cancer	1.1e-05	0.000407	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—POMC—adrenal gland cancer	1.09e-05	0.000406	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.05e-05	0.00039	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MED12—adrenal gland cancer	1.05e-05	0.00039	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.05e-05	0.000388	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.04e-05	0.000387	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—adrenal gland cancer	1.03e-05	0.000381	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MED12—adrenal gland cancer	1.02e-05	0.00038	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	9.91e-06	0.000368	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—adrenal gland cancer	9.68e-06	0.000359	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MED12—adrenal gland cancer	9.57e-06	0.000355	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.39e-06	0.000348	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—POMC—adrenal gland cancer	8.89e-06	0.00033	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	8.73e-06	0.000324	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	8.58e-06	0.000319	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.56e-06	0.000318	CbGpPWpGaD
Losartan—ALB—Metabolism—PRKACA—adrenal gland cancer	8.53e-06	0.000317	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SDHD—adrenal gland cancer	8.47e-06	0.000314	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RRM1—adrenal gland cancer	8.47e-06	0.000314	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	8.39e-06	0.000311	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	8.34e-06	0.00031	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—adrenal gland cancer	8.3e-06	0.000308	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MED12—adrenal gland cancer	8.18e-06	0.000304	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—POMC—adrenal gland cancer	8.15e-06	0.000303	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GNAS—adrenal gland cancer	8.03e-06	0.000298	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	7.88e-06	0.000293	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	7.66e-06	0.000284	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.49e-06	0.000278	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PRKACA—adrenal gland cancer	7.48e-06	0.000278	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.31e-06	0.000271	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—adrenal gland cancer	7.09e-06	0.000263	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	6.98e-06	0.000259	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GNAS—adrenal gland cancer	6.96e-06	0.000258	CbGpPWpGaD
Losartan—ALB—Metabolism—GNAS—adrenal gland cancer	6.92e-06	0.000257	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.83e-06	0.000253	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	6.83e-06	0.000253	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—adrenal gland cancer	6.79e-06	0.000252	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—adrenal gland cancer	6.57e-06	0.000244	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—adrenal gland cancer	6.5e-06	0.000241	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MED12—adrenal gland cancer	6.31e-06	0.000234	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GNAS—adrenal gland cancer	6.21e-06	0.00023	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	6.09e-06	0.000226	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GNAS—adrenal gland cancer	6.06e-06	0.000225	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	5.97e-06	0.000222	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.83e-06	0.000217	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GNAS—adrenal gland cancer	5.66e-06	0.00021	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	5.55e-06	0.000206	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—adrenal gland cancer	5.52e-06	0.000205	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—adrenal gland cancer	5.45e-06	0.000202	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POMC—adrenal gland cancer	5.41e-06	0.000201	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GNAS—adrenal gland cancer	4.84e-06	0.00018	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	4.75e-06	0.000176	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POMC—adrenal gland cancer	4.68e-06	0.000174	CbGpPWpGaD
Losartan—ALB—Metabolism—POMC—adrenal gland cancer	4.66e-06	0.000173	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	4.61e-06	0.000171	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	4.31e-06	0.00016	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POMC—adrenal gland cancer	4.18e-06	0.000155	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POMC—adrenal gland cancer	4.08e-06	0.000151	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POMC—adrenal gland cancer	3.81e-06	0.000141	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	3.74e-06	0.000139	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNAS—adrenal gland cancer	3.73e-06	0.000139	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—adrenal gland cancer	3.71e-06	0.000138	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	3.66e-06	0.000136	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	3.33e-06	0.000124	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POMC—adrenal gland cancer	3.26e-06	0.000121	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—adrenal gland cancer	3.25e-06	0.000121	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	3.04e-06	0.000113	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	2.6e-06	9.64e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.51e-06	9.33e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2e-06	7.44e-05	CbGpPWpGaD
